Magnesium (Elemental Mg) vs. Vitamin B6 (Pyridoxal 5'-Phosphate / PLP)
Comparing 2 standards across 9 specifications. 9 key differences identified.
Magnesium is an essential macromineral required as an enzymatic cofactor in over 300 biochemical reactions including ATP synthesis, DNA replication, and neuromuscular transmission. Adult RDA is 400–420mg (men) / 310–320mg (women).
Vitamin B6 is a water-soluble pyridine vitamin acting via its active coenzyme Pyridoxal 5'-Phosphate (PLP) in over 140 amino acid decarboxylation, transamination, and neurotransmitter synthesis reactions. Adult RDA is 1.3–1.7 mg, with a Tolerable Upper Limit of 100 mg/day.
Specification Comparison Table
9 Parameters| Parameter / Spec | ||
|---|---|---|
|
Nutrient Type
|
Essential Macromineral | Water-Soluble Pyridine Vitamin |
|
Adult RDA / RDI
|
400 – 420 mg / day (Men) / 310 – 320 mg / day (Women) | 1.3 mg / day (Adults 19–50) / 1.7 mg (Men 51+) / 1.5 mg (Women 51+) |
|
Tolerable Upper Limit (UL)
|
350 mg / day (From supplemental forms only; no limit on whole foods) | 100 mg / day (US FDA/NIH) / 12 mg / day (EFSA, revised down from 25mg in 2023) (Avoid sensory peripheral neuropathy) |
|
Chemical Forms
|
Magnesium Glycinate (Chelate), Citrate, Malate, Oxide, L-Threonate | Pyridoxal 5'-Phosphate (PLP, active coenzyme), Pyridoxine HCl, Pyridoxamine |
|
Primary Biological Function
|
Mg-ATP complex cofactor (>300 enzymes), NMDA receptor gatekeeper, Protein synthesis, Muscle relaxation | Transamination / deamination of amino acids, Serotonin / Dopamine / GABA synthesis from amino acids, Glycogen phosphorylase cofactor, Heme synthesis |
|
Deficiency Condition
|
Muscle cramps, Tremors, Ventricular arrhythmias, Insulin resistance, Insomnia | Microcytic sideroblastic anemia, Seborrheic dermatitis, Cheilosis, Peripheral neuropathy, Convulsions |
|
Top Whole Food Sources
|
Pumpkin Seeds, Hemp Hearts, Chia Seeds, Almonds, Spinach, Black Beans, Dark Chocolate | Chickpeas, Wild Salmon, Yellowfin Tuna, Beef Liver, Chicken Breast, Russet Potatoes, Bananas |
|
Cellular Distribution
|
99% intracellular (60% bone, 39% skeletal muscle, <1% serum) | — |
|
Neurotoxicity Threshold
|
— | Chronic megadosing of Pyridoxine HCl (>200–500mg/day) causes reversible sensory neuropathy due to competitive inhibition of tissue PLP |